Restoration of aortopulmonary shunt patency.

[1]  Richard V. Williams,et al.  How many echocardiograms are necessary for follow-up evaluation of patients with Kawasaki disease? , 2001, The American journal of cardiology.

[2]  J. Ruiz,et al.  Implantación de stents en la fístula de Blalock-Taussig en un adulto con atresia pulmonar y comunicación interventricular , 1999 .

[3]  A. Wessel,et al.  Reduced frequency of occlusion of aorto-pulmonary shunts in infants receiving Aspirin , 1999, Cardiology in the Young.

[4]  A. Redington,et al.  Use of self expanding stents in stenotic aortopulmonary shunts in adults with complex cyanotic heart disease , 1999, Heart.

[5]  M. Peuster,et al.  Transcatheter recanalization and subsequent stent implantation for the treatment of early postoperative thrombosis of modified Blalock-Taussig shunts in two children. , 1998, Catheterization and cardiovascular diagnosis.

[6]  M. A. Ali Khan,et al.  Results of 546 Blalock-Taussig shunts performed in 478 patients , 1998, Cardiology in the Young.

[7]  R. Burke,et al.  Emergent stent placement for acute Blalock-Taussig shunt obstruction after stage 1 Norwood surgery. , 1997, Catheterization and cardiovascular diagnosis.

[8]  W. Williams,et al.  The modified Blalock-Taussig shunt: clinical impact and morbidity in Fallot's tetralogy in the current era. , 1997, The Journal of thoracic and cardiovascular surgery.

[9]  K. Tsai,et al.  Modified Blalock-Taussig shunt: statistical analysis of potential factors influencing shunt outcome. , 1996, The Journal of cardiovascular surgery.

[10]  B. McCrindle,et al.  Endovascular stents in the pulmonary circulation. Clinical impact on management and medium-term follow-up. , 1995, Circulation.

[11]  J. von der Emde,et al.  [Thrombolysis of modified Blalock-Taussig shunts in childhood with recombinant tissue-type plasminogen activator]. , 1995, Zeitschrift fur Kardiologie.

[12]  G. Pongiglione,et al.  Balloon dilatation of critically obstructed modified (polytetrafluoroethylene) Blalock-Taussig shunts. , 1994, The American journal of cardiology.

[13]  J. Lock,et al.  Implantation and Intermediate‐Term Follow‐up of Stents in Congenital Heart Disease , 1993, Circulation.

[14]  J. Ormiston,et al.  Percutaneous balloon angioplasty for early postoperative modified Blalock-Taussig shunt failure. , 1993, Catheterization and cardiovascular diagnosis.

[15]  J. Monro,et al.  Twelve year experience with the modified Blalock-Taussig shunt in neonates. , 1992, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[16]  A. Mehta,et al.  Percutaneous transluminal balloon angioplasty of stenotic standard Blalock-Taussig shunts: effect on choice of initial palliation in cyanotic congenital heart disease. , 1991, Journal of the American College of Cardiology.

[17]  J. Kan,et al.  Late outcome after successful balloon dilatation of Blalock-Taussig variant shunt stenosis. , 1991, The American journal of cardiology.

[18]  G. Marx,et al.  Balloon dilation angioplasty of Blalock-Taussig shunts. , 1988, The American journal of cardiology.

[19]  J. Lock,et al.  Balloon Dilation Angioplasty of Hypoplastic and Stenotic Pulmonary Arteries , 1983, Circulation.